Summit Therapeutics
Manufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Brickell Key Dr Ste 1000, Miami, Flo...Phone Number
(650) 382-0001Website
www.smmttx.comRevenue
$33.6 MillionStock Symbol
SMMTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Summit Therapeutics
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.Explore more
Summit Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Summit Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Summit Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Summit Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Summit Therapeutics launches new products
Check out if Summit Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Summit Therapeutics has new funding data
Summit Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Summit Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Summit Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Summit Therapeutics
Compare insights from companies similar to Summit Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Summit Therapeutics
$33.6M
201-500
Public
$1.2B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
$827.1M
501-1,000
Public
$2.5B
1998
QN
Quintus NgumahVice President, Clinical Development & Chief Marketing Officer, Cos To The
Company Profile Activity
Activity Insights
Summit Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Summit Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Summit Therapeutics.
Summit Therapeutics financials insights
Gather financial insights about Summit Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$34.2M
2024
Share Placement
$200M
2025
Stock/Share Issuance
$500M
Stock/Share Issuance
$500M
Summit Therapeutics Tech Stack
A closer look at the technologies used by Summit Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Events
Person-Based
Events
Summit Therapeutics News & Media
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
Cancer treatment is undergoing one of the most significant transformations in modern medical history.Summit Therapeutics finance chief tops list of public CFO pay in 2025
Manmeet Soni, finance chief of the oncology company, had total compensation of nearly $250 million last year, the highest among CFOs at publicly traded firms in America.Summit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Summit Therapeutics Inc. (SMMT) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:00 AM EDTCompany ParticipantsAllen Yang - Head...Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best high short interest stocks with highest upside potential. On May 31, Summit Therapeutics announced positive Phase III overall survival/OS results from the HARMONi-6 trial, which evaluated ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in patients with advanced squamous non-small cell lung cancer/NSCLC. The study showed that […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Summit Therapeutics
Sign Up For FreeTo access detailed company insights
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.... Read More
